What did MBK Partners pay for Medit Corp.?

MBK Partners acquired Medit Corp. for $2.00B in 2022 (16.3x EBITDA), equivalent to 9.10x revenue. Target revenue was approximately $220.9M. Target EBITDA was approximately $122.7M.

What does Medit Corp. do?

Medit Corp. is a dental practice business.

What multiple did MBK Partners pay for Medit Corp.?

16.3x EBITDA and 9.10x revenue, based on disclosed deal value of $2.00B and disclosed financials.

M&A TRANSACTION · 2022

Medit Corp. acquired by MBK Partners

$2.00B· 16.3x EBITDA· 9.10x revenue

Target

Medit Corp.

Acquirer

MBK Partners

Disclosed financials at time of acquisition

Revenue

$220.9M

EBITDA

$122.7M

Deal Value

$2.00B

EV/EBITDA

16.3x

Context

This $2.00B acquisition of Medit Corp. by MBK Partners sits in the dental practice sub-vertical. The 16.3x EBITDA multiple paid in 2022 can be compared against the population median for dental practice transactions of similar size on our Dental Practice valuation hub.

Source

Data sourced from Press release. All figures reflect disclosed values at the time of the acquisition; no estimated or imputed data. Methodology

Value your own dental practice

Get an instant valuation range for your business. Backed by 25,592 real M&A transactions.

Compare your business to the Medit Corp. acquisition.

Citation: ExitValue.ai. (2022). Medit Corp. acquired by MBK Partners. https://exitvalue.ai/deals/medit-corp-acquired-by-mbk-partners-hc-2022-0054